Cannabinoids and cancer: A look into research coming out of Tel Aviv with Professor Dan Peer

Professor Dan Peer.

Grow Tech Labs and NICHE Canada are organizing an event in Vancouver featuring Tel Aviv University professor Dan Peer.

The Feb. 21 talk will delve into research related to cannabinoids and cancer.

Peer is a Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is also the Chair of Tel Aviv University Cancer Biology Research Center – the biggest Cancer Center in Israel that includes 17 affiliated hospitals.

Peer’s work was among the first to demonstrate systemic delivery of RNA molecules using targeted nanocarriers to the immune system and he pioneered the use of RNA interference (RNAi) and modified mRNA for in vivo validation of new drug targets within the immune system that has enormous implications in cancer and inflammation.

Peer has more than 90 pending and granted patents. Some of them have been licensed to several pharmaceutical companies and one is currently under registration (as a new drug in inflammatory bowel disease).

In addition, based on his work, four spin-off companies were generated aiming to bring innovative personalized medicine into clinical practice.

Peer is now studying the use of cannabinoids (both natural and synthetic) in cancer, non-alcoholic liver diseases and in inflammatory bowel diseases going all the way from the lab into the clinic.

Peer is a scientific advisory board member in more than 10 companies, four of them are public companies. He is also a past President of the Israeli Chapter of the Controlled Release Society, and a Member of the Israel Young Academy of Science.

The event is set for Feb. 21 at Grow Tech Labs (#300 128 West Hastings St., Vancouver). Tickets are by donation.

Click here for more information and for tickets.

LEAVE A REPLY

Please enter your comment!
Please enter your name here